Start Date
March 31, 2014
Primary Completion Date
March 31, 2015
Study Completion Date
July 31, 2015
Ranibizumab
monthly ranibizumab (0,5 mg injected intravitreally in a standard fashion) until maximum visual acuity (VA) is achieved and remains stable for three consecutive months (for a minimum of 3 initial injections).
Dept of Ophthalmology - UNIFESP/Hospital São Paulo, São Paulo
Collaborators (1)
Novartis
INDUSTRY
Federal University of São Paulo
OTHER